THE US Food and Drug Administration has approved Ogivri (trastuszumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer whose tumours overexpress the HER2 gene.
MODELLING commissioned by the Pharmacy Guild of Australia suggests that the goals outlined in its recently released 10-year vision, Towards 2035 (PD 06 Aug), could amount to $5.1 billion in healthcare savings if realised.
TERRYWHITE Chemmart is travelling around the country with its annual Leaders’ Academy, bringing two days of hands-on learning to pharmacy leaders in every state this month.
CHEMIST Warehouse has raised $1.27 million to support the Gotcha4Life Foundation as part of its 2025 Men’s Health Campaign, a national initiative to promote mental fitness and work towards reducing suicide rates in Australia.
Notifications
